In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clarins Bright Plus Addresses Skin Hyper Pigmentation

This article was originally published in The Rose Sheet

Executive Summary

Clarins Bright Plus Total Brightening Serum contributed to a more even complexion, more radiant skin and a reduction in the intensity of pigmentation marks after three months of use in clinical testing, the French company said

You may also be interested in...



Clarins Adds 21-Day Program To Brightening Skin Care Lineup

Clarins Intensive Age-Control Brightening Program lifts, firms and brightens skin in 21 days, according to the firm. The product is the French beauty company's first formula to combine brightening and anti-aging ingredients, Clarins added

Clarins Adds 21-Day Program To Brightening Skin Care Lineup

Clarins Intensive Age-Control Brightening Program lifts, firms and brightens skin in 21 days, according to the firm. The product is the French beauty company's first formula to combine brightening and anti-aging ingredients, Clarins added

Clinique Brightens Up Skin Care Portfolio With Spring Launch Initiatives

Clinique is moving into the skin brightening category with the debut of Clinique Derma White, a 17-product range customized by skin type and concern, according to the Estee Lauder division

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012111

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel